Drug Shortage Report for JAMP-BICALUTAMIDE
Report ID | 165929 |
Drug Identification Number | 02357216 |
Brand name | JAMP-BICALUTAMIDE |
Common or Proper name | Bicalutamide Tablets, USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | BICALUTAMIDE |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 (blister pack) |
ATC code | L02BB |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-08-01 |
Estimated end date | 2022-11-10 |
Actual end date | 2022-10-21 |
Shortage status | Resolved |
Updated date | 2022-10-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-08-03 | English | Compare |
v2 | 2022-08-03 | French | Compare |
v3 | 2022-09-19 | English | Compare |
v4 | 2022-09-19 | French | Compare |
v5 | 2022-10-07 | English | Compare |
v6 | 2022-10-07 | French | Compare |
v7 | 2022-10-24 | English | Compare |
v8 | 2022-10-24 | French | Compare |
Showing 1 to 8 of 8